Riskpilot← Back to searchSign inGet full accessABC BIOSCIENCE AS
ASActiveOrg 994576313Haraldsgata 90, 3. Etasje, 5528 HaugesundTechnical testing and analysis · NACE 7120Est. 20090 employees
Revenue 2024
NOK 0
EBITDA margin
—
-10% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK 20K
+4% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -15K | -10% |
| Net profit | NOK 20K | +4% |
| Total assets | NOK 8,5M | +882% |
| Equity | NOK 8,5M | +5078% |
| Employees | 0 | — |
Legal name
ABC BIOSCIENCE AS
Org number
994576313
Legal form
Aksjeselskap
NACE code
7120 · Technical testing and analysis
Founded
30. september 2009
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Geir utne berg
Company purpose
Forskning, utvikling og produksjon av næringsmidler, aktive stoffer samt deltakelse i andre selskaper.
Address
Haraldsgata 90, 3. Etasje, 5528 Haugesund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 157 | 193 | 673 | 1 476 | 1 574 | 2 080 | 721 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −200 | −0 | −589 | −1 094 | −1 247 | −1 663 | −765 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −48 | −1 347 | −1 192 | −1 176 | −1 410 | −2 302 | −2 347 | −2 266 | −43 | −22 | −11 | −11 | −11 | −13 | −14 | −15 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −48 | −1 347 | −1 192 | −1 176 | −1 410 | −2 302 | −2 347 | −2 266 | −43 | −22 | −11 | −11 | −11 | −13 | −14 | −15 |
| Net financials | 1 | 7 | 4 | 3 | −3 | 4 | −90 | 5 | 6 | 9 | 13 | 6 | 3 | 15 | 34 | 36 |
| Profit before tax | −48 | −1 340 | −1 188 | −1 173 | −1 413 | −2 297 | −2 437 | −2 261 | −36 | −12 | 3 | −5 | −8 | 2 | 20 | 20 |
| Tax | −13 | 13 | 0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −34 | −1 353 | −1 188 | −1 173 | −1 413 | −2 297 | −2 437 | −2 261 | −36 | −12 | 3 | −5 | −8 | 2 | 20 | 20 |
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 124 | 252 | 333 | 4 785 | 5 263 | 2 239 | 1 923 | 911 | 871 | 857 | 5 660 | 855 | 847 | 849 | 869 | 8 537 |
| Equity | 66 | −1 287 | −2 476 | 120 | 1 798 | 100 | −2 337 | −4 598 | −4 635 | −4 647 | 156 | 151 | 143 | 145 | 165 | 8 537 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 504 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 58 | 1 539 | 2 809 | 4 664 | 3 466 | 2 138 | 4 260 | 6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total debt | 58 | 1 539 | 2 809 | 4 664 | 3 466 | 2 138 | 4 260 | 5 510 | 5 505 | 5 504 | 5 504 | 704 | 704 | 704 | 704 | 0 |
EBITDA margin
-1541300.0%
This company
15.8%
Market median
-9755163% vs market
20092024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20092024
Return on equity
0.2%
This company
18.4%
Market median
-99% vs market
20092024
Net profit margin
2048500.0%
This company
8.1%
Market median
+25290023% vs market
20092024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20092024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-09-22 – 2009-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ES Deputy Member | Deputy Member | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bifrost Og Draupne Holding As | Company | 100.0% | 100.0% | 2024 |
Bifrost Og Draupne As | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sera As
ABC BIOSCIENCE AS Board members of ABC BIOSCIENCE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eystein Sævareid Aase | Deputy Member | 0 companies |
| Sigurd Steen Aase | Chairman | 0 companies |